Takeda Pharmaceutical Ltd ADR (TAK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Sales | 7,415,989 | 7,457,205 | 7,103,466 | 7,905,716 | 7,542,747 |
| Cost of Goods | 2,346,635 | 2,214,125 | 2,191,449 | 2,572,090 | 2,526,903 |
| Gross Profit | 5,069,354 | 5,243,080 | 4,912,017 | 5,333,626 | 5,015,843 |
| Operating Expenses | 4,615,941 | 3,687,455 | 4,946,922 | 4,841,416 | 4,640,617 |
| Operating Income | 454,048 | 1,555,750 | -34,457 | 492,301 | 376,129 |
| Interest Expense | 600,416 | 435,668 | 201,695 | 402,380 | 494,797 |
| Other Income | 101,905 | 91,624 | -300,088 | 138,626 | 96,618 |
| Pre-tax Income | -44,462 | 1,211,706 | -536,240 | 228,546 | -22,050 |
| Income Tax | -82,720 | 444,280 | -925,452 | 523,922 | -523,469 |
| Net Income Continuous | 38,258 | 767,427 | 389,212 | -295,375 | 501,419 |
| Minority Interests | 310 | 74 | -1,495 | 1,058 | 670 |
| Net Income | $37,948 | $767,352 | $390,707 | $-296,433 | $500,749 |
| EPS Basic Total Ops | 0.01 | 0.25 | 0.13 | -0.10 | 0.16 |
| EPS Basic Continuous Ops | 0.01 | 0.25 | 0.13 | -0.09 | 0.16 |
| EPS Diluted Total Ops | 0.01 | 0.25 | 0.13 | -0.10 | 0.16 |
| EPS Diluted Continuous Ops | 0.01 | 0.25 | 0.12 | -0.09 | 0.16 |
| EBITDA(a) | $1,774,280 | $2,872,510 | $1,306,242 | $1,340,853 | $1,951,829 |